NM_024675.4(PALB2):c.2363C>A (p.Thr788Asn) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Nov 5, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002442454.2
Allele description [Variation Report for NM_024675.4(PALB2):c.2363C>A (p.Thr788Asn)]
NM_024675.4(PALB2):c.2363C>A (p.Thr788Asn)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Homo sapiens Bcl2 modifying factor (BMF), transcript variant 9, mRNA
Homo sapiens Bcl2 modifying factor (BMF), transcript variant 9, mRNAgi|2168986061|ref|NM_001398499.1|Nucleotide
-
Homo sapiens Bcl2 modifying factor (BMF), transcript variant 21, non-coding RNA
Homo sapiens Bcl2 modifying factor (BMF), transcript variant 21, non-coding RNAgi|2167384541|ref|NR_174113.1|Nucleotide
-
alpha-2B adrenergic receptor [Mugil cephalus]
alpha-2B adrenergic receptor [Mugil cephalus]gi|2220055753|ref|XP_047447492.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024